UBS Group’s JPMorgan Healthcare Leaders ETF JDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-24
Closed -$1.39K 10840
2025
Q4
$1.39K Sell
24
-527
-96% -$29.7K ﹤0.01% 9601
2025
Q3
$28.9K Buy
551
+453
+462% +$23K ﹤0.01% 7919
2025
Q2
$4.95K Buy
+98
New +$4.91K ﹤0.01% 9226
2024
Q4
Sell
-17
Closed -$1.03K 10176
2024
Q3
$1.03K Buy
+17
New +$1.03K ﹤0.01% 8744

Other funds holding JDOC

UBS Group's JDOC Position: Q1 2026 in Review

UBS Group sold out of JPMorgan Healthcare Leaders ETF (JDOC) in Q1 2026, closing a stake of 24 shares — an estimated $1.39K sold.

UBS Group first reported a position in JDOC in Q3 2024 and held it in 4 quarters. The position peaked at $28.9K in Q3 2025. 9 funds tracked by Wall St. Rank hold JDOC as of Q1 2026.

  • UBS Group reported no remaining JPMorgan Healthcare Leaders ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 24 JPMorgan Healthcare Leaders ETF shares in Q1 2026, an estimated $1.39K.
  • UBS Group first reported a position in JPMorgan Healthcare Leaders ETF in Q3 2024 and held it in 4 quarters.
  • UBS Group's JPMorgan Healthcare Leaders ETF position peaked at $28.9K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held JPMorgan Healthcare Leaders ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.